Press

Home
Press

2024/07/09

PoleSocieties: Incontinence urinaire, Uromems lève 44 millions d’euros

https://polesocietes.com/actualites/levee-de-fonds/incontinence-urinaire-uromems-leve-44-millions-d-euros

CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use only. Exclusively for Clinical Investigations.

*UroMems’ product, UroActive™ is under development. Its properties, performance and safety are still under evaluation. It is not available yet for prescription, delivery, sale or use by any patient or health care professional. As a medical device, it does not yet comply with Regulation (EU) 2017/745. UroActive™ is not CE marked.

Follow us on :

Credits and legal notice|Site map|Contact us